entertainment -WSS

entertainment

author：comprehensive 2025-08-12 09:13:34 - browse：7

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The aspartame in Diet Coke probably isn’t giving you cancer

knowledge

focus

WSS

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

The U.S. needs a new definition of substance use “recovery”

Think you might have Covid

eGenesis tests gene

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Wikipedia

entertainment

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wisconsin governor employs partial veto to fund schools for 4 centuries

Hollywood unions extend contract negotiations for actors

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Moonlake's readout produced a cash windfall. Risks remain

The surgeon had a dilemma only a Nazi medical text could resolve

Continuity nursing helped my family in our darkest PICU moments

Biden targets hefty hospital 'facility fees' that often surprise patients

BioMarin wins approval for gene therapy to treat hemophilia A

Presidential fundraising highlights so far: Trump brings in more than DeSantis

focus

Copay coupons to count toward deductibles, after Biden court move

Francis Collins on trust in science and how Covid communications failed

Elizabeth Holmes banned from government health programs

The U.S. needs a new definition of substance use “recovery”

Think you might have Covid

Test for long Covid? Researchers find new clue in blood samples

Wikipedia

knowledge

focus

knowledge